Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure


Alkis N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., ...More

JOURNAL OF BUON, vol.16, no.1, pp.80-83, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 1
  • Publication Date: 2011
  • Title of Journal : JOURNAL OF BUON
  • Page Numbers: pp.80-83

Abstract

Purpose: To retrospectively evaluate the efficacy and tolerability of mitomycin-C (MMC) in combination with fluoropyrimidines as salvage 3rd -or 4th-line therapy in metastatic colorectal cancer (MCRC) patients.